key: cord-0896990-jhqdurad
authors: Ladlow, Peter; O’Sullivan, Oliver; Houston, Andrew; Barker-Davies, Robert; May, Samantha; Mills, Daniel; Dewson, Dominic; Chamley, Rebecca; Naylor, Jon; Mulae, Joseph; Bennett, Alexander N.; Nicol, Edward D.; Holdsworth, David A.
title: Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms, but is associated with objective functional limitations
date: 2021-12-09
journal: Heart Rhythm
DOI: 10.1016/j.hrthm.2021.12.005
sha: b4f1e3db08b5fd799ba6ddd85077dbc5e0edac21
doc_id: 896990
cord_uid: jhqdurad

BACKGROUND: Individuals who contract coronavirus disease 2019 (COVID-19) can suffer with persistent and debilitating symptoms long after the initial acute illness. Heart rate (HR) profiles determined during cardiopulmonary exercise testing (CPET) and delivered as part of a post-COVID recovery service may provide an insight into presence and impact of dysautonomia on functional ability. OBJECTIVE: Using an active, working age, post-COVID-19 population, the aim was to: 1) understand and characterise any association between subjective symptoms and dysautonomia, and 2) identify objective exercise capacity differences between patients classified ‘with’ and ‘without’ dysautonomia. METHODS: Patients referred to a post-COVID-19 service underwent comprehensive clinical assessment, including self-reported symptoms, CPET and secondary care investigations when indicated. Resting HR >75 beats per minute (bpm), HR increase with exercise <89bpm, and HR recovery <25bpm one minute after exercise were used to define dysautonomia. Anonymised data were analysed and associations with symptoms and CPET outcomes determined. RESULTS: Fifty-one (25%) of the 205 patients reviewed as part of this service evaluation had dysautonomia. There were no associations between symptoms or perceived functional limitation and dysautonomia (p>0.05). Patients with dysautonomia demonstrated objective functional limitations with significantly reduced work rate (219±37 W vs. 253±52 W, p<0.001), peak oxygen consumption (V̇O(2): 30.6±5.5 ml/kg/min vs. 35.8±7.6 ml/kg/min, p<0.001) and a steeper (less efficient) V̇E/V̇CO(2) slope (29.9±4.9 vs. 27.7±4.7, p=0.005). CONCLUSION: Dysautonomia is associated with objective functional limitations but is not associated with subjective symptoms or limitation.

Exercise provides a safe means to expose imbalances in parasympathetic and sympathetic 90 activity which may be hidden at rest. 7 HR is recorded throughout a cardiopulmonary exercise 91 test (CPET), and exercise HR profiles are prognostically important. 8 Heart rate variability 92 (HRV) (variability in the time interval between heart beats) recorded at rest is a well-93 validated marker of parasympathetic tone and is associated with the severity of acute 94 COVID-19 illness. 9 95 96 Most literature on the effects of COVID-19 focuses on severe acute illness, typically in 97 vulnerable older adults with pre-morbid health conditions. 10 The long-term effects of SARS-Age, sex, height, body mass and details of acute COVID-19 illness were recorded at the start 126 of each admission. 127

Cardiopulmonary exercise testing (CPET) 130

CPET was performed on an electro-magnetically braked cycle ergometer (Lode Carnival, 131

Lode BV, Netherlands) at 16 to 18ºC, with indirect calorimetry (Metalyzer 3B, Cortex 132

Biophysik, Germany). The CPET protocol followed at least 5 minutes of rest. Two-minute 133 resting recording was followed by a two-minute unloaded cycling at a cadence of 60 134 revolutions per minutes (rpm), before introduction of a 25W resistance followed by a 135 progressive increasing workload to volitional fatigue. The work rate/min ramp was selected 136 to achieve 8 to 12 minutes of loaded exercise. Continuous measurement of ventilation (V E), 137 oxygen consumption (V O2), expired carbon dioxide (V CO2), HR, electrocardiogram (ECG), 138 peripheral oxyhaemoglobin saturation (SpO2) and workload were performed throughout the 139 rest, exercise and recovery phases. 13 Maximal tests were defined by respiratory exchange 140 ratio (RER) >1.1 and/or a ≥30 s plateau in oxygen. Blood pressure, SpO2, rate of perceived 141 exertion (RPE, 6 -20 Borg Scale) 14 and dyspnea (0-10,'Modified Borg Scale') 15 were 142 recorded every two minutes. Following attainment of maximal exercise capacity, participants 143 remained stationary on the ergometer for at least three minutes. Forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) were 149 recorded.

Jouven's criteria 8 were employed for the diagnosis of exercise-associated dysautonomia: 1) a 153 resting HR >75 beats per minute (bpm); 2) an increase in HR during exercise of <89bpm; and 154

3) a HR recovery <25bpm after the cessation of exercise. A diagnosis of dysautonomia 155 required that all three criteria were met. 156 157

Symptoms with a prevalence of greater than 25% were carried forward for further analysis. All individual raw data files containing R-R intervals were exported to Excel™, before being 167 read in Python. Automatic detection and removal of ectopic beats from the raw R-R intervals 168 was performed using the method described by Acar et al. 17 with the output inspected 169 manually. Missing values were replaced using linear interpolation. Following preprocessing 170 of the R-R intervals, the root square of the mean of squared differences of adjacent RR 171 intervals (RMSSD), a measure of beat-to-beat variability, 16 was calculated. RMSSD is the 172 primary time-domain measure used to estimate the vagal-mediated changes reflected in phase. 19,20 All analysis was conducted using Python 3.7 (Python Software Foundation, 176

Wilmington, United States). 177 178

The normality of all variables within the dataset was assessed using a Shapiro-Wilk test and 180 inspection of the Q-Q plots, demonstrating normal distribution across most of variables. 181

Given the sample size was sufficiently large (n=205) parametric tests were applied 182 throughout. 21 The most prevalent symptoms (prevalence > 25%) were extracted and tests of 183 associations between the classification of dysautonomia and each symptom were performed 184 using chi-squared tests. To determine the effect of dysautonomia, independent sample t-tests 185

were conducted for CPET-related variables, identifying objective physiological differences 186 between patients 'with' and 'without' dysautonomia. For all statistical tests, an alpha 187 threshold for significance of 0.05 was applied. All statistical analyses were performed in 188 

The mean duration from the onset of symptoms to the date of CPET assessment for the total 193 cohort was 183±77days (~6-months). No significant differences in the duration between 194 onset of symptoms and assessment date were observed between patients with or without 195 dysautonomia (180±81days vs. 184±76days, p=0.347, respectively). This study identified dysautonomia in a significant proportion (25%) of active, working-age 267 adults assessed at a median 6 months post-acute COVID-19 illness. Using Jouven's criteria to 268 identify those with dysautonomia occurring as part of a maximal exercise test, no clinically 269 significant associations were found with subjective symptoms or exercise intolerance. 270

However, objective functional capacity was reduced in dysautonomia. 271

In normal physiology, maximal exercise capacity is determined by circulatory limitation 273 (cardiac output). Those with dysautonomia are restricted in their ability to augment HR, from 274 rest to peak stress, which reduces capacity to increase peak cardiac output. The mean 275 difference in HR response to exercise was 75±12 bpm in patients with dysautonomia vs. 276 96±13 bpm in those without. This is despite a somewhat elevated resting HR in all groups 277 84±13 bpm that the authors conclude is primarily due to anticipatory HR response prior to a 278 maximal exercise challenge. Although peak HR was lower in the group with dysautonomia 279 HR at VT1 was higher. Given that this is the point of transition to mixed aerobic and 280 anaerobic metabolism, the higher HR may be implicated in reduced exercise capacity. Work 281 rate at VT1 and peak exercise were significantly lower in patients with dysautonomia. During CPET, there were no differences in subjective symptoms of breathlessness at rest, 290 VT1 or peak exercise, and the only difference in RPE values were demonstrated at peak RPE. 291

The magnitude of this difference was trivial. These findings demonstrate that symptoms of 292 post-COVID-19 syndrome are not predictive of dysautonomia. They also suggest that 293 dysautonomia is unlikely to be a significant contributor to symptoms. 294

The measurement of HRV immediately following peak exercise did not reveal 296 pathophysiological insights beyond the HR profiles used as an indirect measure of 297 dysautonomia. 8 Given how strongly dependent HRV is on resting HR, 22 this finding is 298 perhaps unsurprising. The added benefit of utilising HR recovery following maximal exercise in the indirect measure of dysautonomia 8 was that HR recovery is a highly reproducible 300 measure of an individual's vagal tone. It is independent of other physiological measures, 301 including resting HR. 7 302 303 There was a strong association between dysautonomia and lower ventilatory efficiency. Patients with dysautonomia demonstrate a less favourable body composition to those without 317 dysautonomia (higher BMI and waist circumference). It is not possible to determine whether 318 this reflects an increased risk of complex acute COVID-19 illness, the potential of post-319 COVID complications in those with a high BMI, or pre-morbid reduced cardiovascular 320 fitness. Another possible factor is post-COVID debility reducing exercise capacity 321 sufficiently to contribute to weight gain. Sex has previously been shown to be a risk factor for 322 dysautonomia. 24 We identified no sex difference. neuroradiology biomarkers of brain function associated with dysautonomia in an effort to 344 identify a mechanism for dysautonomia in this setting. 345

Data has been collected from serving UK Armed Forces personnel. As such, their data is 375 sensitive and will not be published on an open registry. Requests for the anonymised data 376 used for analysis can be directed to the corresponding author, who will liaise with the 377 appropriate authority for consideration. 

Persistent symptoms 3 months after 386 a SARS-CoV-2 infection: the post-COVID-19 syndrome?

Alteration of autonomic nervous system is associated 399 with severity and outcomes in patients with COVID-19. Frontiers in physiology

Clinical and 406 Occupational Assessment Prior to Return to Duty and Training post COVID-19 In: 950 JSP, 407 editor

ERS statement on standardisation of 409 cardiopulmonary exercise testing in chronic lung diseases

Psychophysical bases of perceived exertion. Medicine and science in sports 412 and exercise

Perception of breathlessness during exercise in 414 patients with respiratory disease

Cardiac autonomic responses during exercise 416 and post-exercise recovery using heart rate variability and systolic time intervals-a review. Abbreviations: VT1 = 1 st ventilatory threshold, HR = heart rate, HRR = heart rate recovery, RMSSD = root mean square of successive differences of R-R intervals, BP = blood pressure, BF = breathing frequency